Heidelberg Pharma has reported encouraging progress in its phase 2/2a trial of HDP-101 (INN: pamlectabart tismanitin), its ...
The Christie NHS Foundation Trust has completed a four-month digital transformation project using Netcall’s Liberty Spark to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback